Position in TMO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,044,834
-$88,142 QoQ
Shares Held
2,084
-9.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,429
of 2,602 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Savvy Advisors, Inc. holds $3,865,622 across 7 Diagnostics & Research names. TMO ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,084 | $1,044,834 | |
| 2 | DGX |
Quest Diagnostics Inc
|
3,847 | $815,371 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,265 | $665,946 | |
| 4 | DHR |
Danaher Corp /De/
|
2,681 | $510,676 | |
| 5 | GH |
Guardant Health, Inc.
|
2,120 | $318,063 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,511 | $258,331 | |
| 7 | WAT |
Waters Corp /De/
|
673 | $252,401 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,044,834 | 2,084 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,132,976 | 2,305 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,425,447 | 2,460 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $830,354 | 1,712 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $733,477 | 1,809 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $927,526 | 1,864 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $802,714 | 1,543 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,051,569 | 1,700 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $942,865 | 1,705 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||